Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
TSE:4506
Price:
568
JPY
-0.53%
Market Closed
Market Cap:
226B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Sumitomo Pharma Co Ltd
568
-3 (-0.53%)
| 52 Week Range |
285
684
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Sumitomo Pharma Co Ltd
Balance Sheet
Balance Sheet Decomposition
Sumitomo Pharma Co Ltd
Sumitomo Pharma Co Ltd
| Current Assets | 311.9B |
| Cash & Short-Term Investments | 115.9B |
| Receivables | 68.9B |
| Other Current Assets | 127.1B |
| Non-Current Assets | 487.8B |
| Long-Term Investments | 39.4B |
| PP&E | 57.4B |
| Intangibles | 368.5B |
| Other Non-Current Assets | 22.5B |
| Current Liabilities | 486.5B |
| Accounts Payable | 58.6B |
| Other Current Liabilities | 427.9B |
| Non-Current Liabilities | 199.1B |
| Long-Term Debt | 133.4B |
| Other Non-Current Liabilities | 65.6B |
Balance Sheet
Sumitomo Pharma Co Ltd
Sumitomo Pharma Co Ltd
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
30 553
|
54 922
|
105 603
|
147 775
|
137 296
|
101 708
|
193 698
|
202 984
|
143 478
|
29 047
|
|
| Cash Equivalents |
30 553
|
54 922
|
105 603
|
147 775
|
137 296
|
101 708
|
193 698
|
202 984
|
143 478
|
29 047
|
|
| Short-Term Investments |
111 293
|
81 039
|
17 494
|
22 066
|
43 750
|
28 717
|
29 480
|
35 596
|
20 174
|
7 085
|
|
| Total Receivables |
151 999
|
155 587
|
118 966
|
113 401
|
119 243
|
140 368
|
136 060
|
151 500
|
98 630
|
97 239
|
|
| Accounts Receivables |
102 947
|
107 161
|
110 700
|
110 582
|
116 059
|
129 368
|
128 569
|
141 020
|
86 405
|
68 818
|
|
| Other Receivables |
49 052
|
48 426
|
8 266
|
2 819
|
3 184
|
11 000
|
7 491
|
10 480
|
12 225
|
28 421
|
|
| Inventory |
62 387
|
59 587
|
60 286
|
60 169
|
66 889
|
79 368
|
92 215
|
99 021
|
94 405
|
115 350
|
|
| Other Current Assets |
45 467
|
70 449
|
5 211
|
5 170
|
6 090
|
13 929
|
8 342
|
10 420
|
25 173
|
20 848
|
|
| Total Current Assets |
401 699
|
421 584
|
307 560
|
348 581
|
373 268
|
364 090
|
459 795
|
499 521
|
381 860
|
269 569
|
|
| PP&E Net |
65 160
|
61 824
|
61 121
|
58 204
|
59 485
|
65 748
|
64 966
|
64 091
|
58 909
|
57 895
|
|
| PP&E Gross |
65 160
|
61 824
|
61 121
|
58 204
|
59 485
|
65 748
|
64 966
|
64 091
|
58 909
|
57 895
|
|
| Accumulated Depreciation |
148 272
|
154 453
|
159 828
|
161 841
|
157 542
|
129 214
|
122 819
|
132 888
|
130 474
|
129 724
|
|
| Intangible Assets |
85 788
|
79 630
|
197 114
|
189 681
|
171 390
|
421 029
|
383 406
|
398 692
|
329 314
|
195 652
|
|
| Goodwill |
88 075
|
76 950
|
100 194
|
95 097
|
99 348
|
173 464
|
176 492
|
195 144
|
209 415
|
199 783
|
|
| Note Receivable |
0
|
0
|
0
|
2 453
|
2 562
|
0
|
6 726
|
5 538
|
6 042
|
6 846
|
|
| Long-Term Investments |
58 193
|
60 432
|
52 681
|
70 993
|
74 668
|
200 923
|
193 035
|
115 844
|
134 007
|
161 711
|
|
| Other Long-Term Assets |
12 668
|
7 295
|
60 402
|
44 675
|
53 996
|
31 280
|
23 707
|
29 177
|
15 195
|
16 050
|
|
| Other Assets |
88 075
|
76 950
|
100 194
|
95 097
|
99 348
|
173 464
|
176 492
|
195 144
|
209 415
|
199 783
|
|
| Total Assets |
711 583
N/A
|
707 715
-1%
|
779 072
+10%
|
809 684
+4%
|
834 717
+3%
|
1 256 534
+51%
|
1 308 127
+4%
|
1 308 007
0%
|
1 134 742
-13%
|
907 506
-20%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
12 492
|
12 153
|
14 514
|
17 512
|
15 498
|
25 640
|
26 076
|
22 455
|
13 403
|
20 765
|
|
| Accrued Liabilities |
0
|
10 809
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
1 010
|
40 000
|
3 500
|
0
|
270 000
|
5 000
|
5 025
|
90 588
|
174 588
|
|
| Current Portion of Long-Term Debt |
36 522
|
22 000
|
18 000
|
12 960
|
3 697
|
9 097
|
11 019
|
25 832
|
4 660
|
114 710
|
|
| Other Current Liabilities |
98 413
|
133 750
|
159 619
|
176 276
|
178 979
|
191 761
|
236 052
|
225 061
|
264 043
|
205 411
|
|
| Total Current Liabilities |
156 843
|
179 722
|
232 133
|
210 248
|
198 174
|
496 498
|
278 147
|
278 373
|
372 694
|
515 474
|
|
| Long-Term Debt |
50 000
|
28 000
|
10 000
|
30 940
|
29 286
|
37 745
|
275 526
|
254 510
|
251 124
|
138 566
|
|
| Deferred Income Tax |
15 704
|
16 209
|
72
|
95
|
0
|
26 768
|
28 424
|
26 550
|
36 505
|
38 211
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
103 190
|
67 608
|
65 681
|
33
|
73
|
|
| Other Liabilities |
36 365
|
37 312
|
124 599
|
115 678
|
109 119
|
59 663
|
77 852
|
75 005
|
67 637
|
59 119
|
|
| Total Liabilities |
260 562
N/A
|
261 243
+0%
|
366 804
+40%
|
356 961
-3%
|
336 579
-6%
|
723 864
+115%
|
727 557
+1%
|
700 119
-4%
|
727 993
+4%
|
751 443
+3%
|
|
| Equity | |||||||||||
| Common Stock |
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
22 400
|
|
| Retained Earnings |
326 686
|
341 401
|
357 769
|
396 037
|
431 799
|
457 330
|
508 677
|
514 210
|
280 999
|
22 665
|
|
| Additional Paid In Capital |
15 860
|
15 860
|
15 860
|
15 860
|
15 861
|
17 837
|
15 855
|
16 725
|
0
|
0
|
|
| Unrealized Security Profit/Loss |
17 247
|
0
|
0
|
31 735
|
32 611
|
46 118
|
38 575
|
23 838
|
39 260
|
64 526
|
|
| Treasury Stock |
660
|
0
|
667
|
669
|
674
|
677
|
679
|
681
|
682
|
682
|
|
| Other Equity |
63 636
|
42 181
|
16 906
|
12 640
|
3 859
|
10 338
|
4 258
|
31 396
|
64 772
|
92 484
|
|
| Total Equity |
451 021
N/A
|
446 472
-1%
|
412 268
-8%
|
452 723
+10%
|
498 138
+10%
|
532 670
+7%
|
580 570
+9%
|
607 888
+5%
|
406 749
-33%
|
156 063
-62%
|
|
| Total Liabilities & Equity |
711 583
N/A
|
707 715
-1%
|
779 072
+10%
|
809 684
+4%
|
834 717
+3%
|
1 256 534
+51%
|
1 308 127
+4%
|
1 308 007
0%
|
1 134 742
-13%
|
907 506
-20%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
397
|
397
|
397
|
397
|
397
|
397
|
397
|
397
|
397
|
397
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
